The present study is designed to test the hypothesis that IFN-stimulated ISRE and GAS control sites on Ch21 are markers for novel candidate genes that are dysregulated in DS/T21-related IFN hypersensitivity, neurodegeneration, and predilections for various autoimmune diseases. This evidence concerns the gene IFNA1 and autoimmune disease.